These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 15704477)
1. [Cognitive dysfunction in patients with Parkinson's disease]. Zakharov VV; Iakhno NN Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):13-9. PubMed ID: 15704477 [TBL] [Abstract][Full Text] [Related]
2. Guideline for the treatment of Parkinson's disease. Carr J; Kies B; Fine J; S Afr Med J; 2009 Oct; 99(10):755-6, 758. PubMed ID: 20128276 [No Abstract] [Full Text] [Related]
4. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset. Hanna-Pladdy B; Pahwa R; Lyons KE J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830 [TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647 [TBL] [Abstract][Full Text] [Related]
6. Medical treatment of Parkinson disease. Stacy M Neurol Clin; 2009 Aug; 27(3):605-31, v. PubMed ID: 19555824 [TBL] [Abstract][Full Text] [Related]
7. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia. Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733 [TBL] [Abstract][Full Text] [Related]
8. Current pharmacotherapeutic treatment options in Parkinson's disease. Rezak M Dis Mon; 2007 Apr; 53(4):214-22. PubMed ID: 17586328 [TBL] [Abstract][Full Text] [Related]
9. Drugs for Parkinson's disease. Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446 [No Abstract] [Full Text] [Related]
10. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166 [TBL] [Abstract][Full Text] [Related]
11. An open study with reversible MAO-A inhibitors in complicated Parkinson's disease. Ruggieri S; Fabbrini G; Bramante L; DePandis F; Stocchi F; Barbanti P; Vacca L; Manfredi M Adv Neurol; 1996; 69():595-8. PubMed ID: 8615185 [No Abstract] [Full Text] [Related]